Feb 19, 2024, 08:39 AM by

CD BioSciences is pleased to announce the launch of their latest self-developed alginate products, looking to fulfill scientific research demands.

Feb 19, 2024, 08:39 AM by

Feb 19, 2024, 08:39 AM by

In the fight against infectious diseases like HIV/AIDS, tuberculosis, and viral hepatitis, scientists are turning to advanced drug delivery for more effective treatments. These systems use tiny particles called nanoparticles to carry antiviral and antimicrobial drugs directly to the infected tissues in the body. By doing this, they can target the specific areas where the viruses or bacteria are causing harm while reducing the risk of side effects in other body parts.

Feb 16, 2024, 09:06 AM by

New Guidance Published in The Lancet Recommends Early Intervention and Use of BIS to Reduce Impact of Arm Lymphedema on Breast Cancer Patients

Feb 15, 2024, 10:39 AM by

Precision medicine and diagnostics solutions company SinguLab has partnered with PointClickCare Technologies Inc., provider of a cloud-based software platform for the senior care continuum, to improve precision care capabilities and access in the long-term and post-acute care (LTPAC) space.

Feb 15, 2024, 10:39 AM by

Superior x-ray inspection of high-speed flow-wrap lines

Feb 15, 2024, 08:45 AM by

HEPA-10X mitigates the spread of infection in high-risk healthcare environments

Feb 15, 2024, 08:45 AM by

New Thermo Scientific Dionex Inuvion Ion Chromatography System streamlines ion analysis and expands analytical testing capabilities for ionic and small polar compounds

Feb 15, 2024, 08:45 AM by

Optibrium today announced the release of StarDrop 7.6, the latest version of its platform for small molecule design, optimisation and analysis. As part of the release, Optibrium introduces a new extension, Idea Tracker, with which medicinal chemists can now easily trace molecular design and optimisation decisions through every step of the complex discovery process, from idea conception to selecting candidates for synthesis.

Feb 15, 2024, 08:45 AM by

PrecisionLife and Metrodora Institute are co-investing in a first-of-its-kind partnership to jumpstart the diagnosis and treatment options for a range of complex, chronic diseases including Long COVID, ME/CFS, ALS, Sjögren's syndrome, and many more.

Feb 15, 2024, 08:37 AM by User Not Found

Bio-IT World | Researchers at University of California San Diego School of Medicine have found that the rules of vaccinology need to be reversed for Staphylococcus aureus (SA), the common and sometimes dangerous bacteria that humans encounter shortly after birth and are continuously exposed to for the remainder of their life.

Feb 14, 2024, 09:04 AM by

Alzheimer’s Research & Therapy: Linus Health Digital Clock and Recall Test Detects Early Cognitive Impairment in Over 80% of Patients Who Were Misclassified in Commonly Used Paper-Based Test

Feb 14, 2024, 09:04 AM by

Personalized Health Basel and Leading Life Sciences Organization Collaborate with MDClone to Drive Innovation

Feb 14, 2024, 00:00 AM by User Not Found

Bio-IT World | Researchers in California have shown that breast cancer patients with RNA expression levels of ENPP1 (ectonucleotide pyrophosphatase/phosphodiesterase 1) in the bottom 50th percentile can confidently be treated with Keytruda (pembrolizumab) as well as surgery. Their cancer would have a zero percent chance of metastasizing in seven years.

Feb 13, 2024, 11:15 AM by

In 2022, the latest data from the International Agency for Research on Cancer's Global Cancer Observatory indicates that ten specific types of cancer collectively represented approximately two-thirds of both new cases and fatalities worldwide. Covering 185 countries and 36 different types of cancer, the rising demand for biologics, including monoclonal antibodies and immunotherapies, has surged due to the increasing incidence of cancer. These innovative treatments are revolutionizing cancer care by enhancing survival rates and minimizing adverse effects.

Feb 13, 2024, 11:15 AM by

Domainex, a leading drug discovery and integrated medicines research partner based in Cambridge UK, opens a new Biology Centre of Excellence to further support collaborations with pharmaceutical and biotechnology companies, patient foundations and leading academic institutions globally.

Feb 13, 2024, 01:00 AM by User Not Found

Bio-IT World | Scientists at the Center for Infection and Immunity (CII) at Columbia University Mailman School of Public Health have created a next-generation sequencing (NGS) technology that employs oligonucleotides (oligos)—short single strands of synthetic DNA—as bait for relevant targets of detection.

Feb 9, 2024, 09:16 AM by

BioTeam, Inc. has been awarded a contract by the National Human Genome Research Institute (NHGRI) to enhance its data ecosystem, accelerating genomic discoveries and improving human health outcomes.

Feb 9, 2024, 09:16 AM by

Feb 9, 2024, 09:16 AM by

Abzena launches LabZient™, an analytical platform accelerating antibody development timelines by combining predictive in-silico evaluation with laboratory methods. LabZient™ streamlines assessment, reduces costs, and enables early measurement of critical quality attributes. Fit-for-purpose across various antibody types, including mAbs and ADCs, LabZient™ enhances efficiency in biopharma development.